Russell 2000 ETF (IWM) 115.74 $IWM The Trader Daily: Dip

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Russell 2000 ETF (IWM) 115.74 $IWM

The Trader Daily: Dip Buyers Pay No Heed to Warning Signs
at The Street - Thu Oct 08, 6:00AM CDT
Yum! Brands, retail stocks get taken down.
DLTR: 63.36 (+1.28), SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), DIA: 170.76 (+0.39), JWN: 68.43 (-0.54), DG: 67.23 (+1.03), IWM: 115.74 (+0.23), PVH: 100.64 (-0.96), YUM: 70.25 (+2.79)

After Yesterday's Rally of 1.77% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 07, 3:42PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $112.63 to a high of $114.50. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $113.67 on volume of 36.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IWM: 115.74 (+0.23)

iShares Russell 2000 Index Fund Set to Possibly Pullback After Yesterday's Rally of 1.77%
Comtex SmarTrend(R) - Wed Oct 07, 3:42PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $112.63 to a high of $114.50. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $113.67 on volume of 36.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IWM: 115.74 (+0.23)

Rally That Began Friday Is an Opportunity to 'Sell on Strength'
at The Street - Mon Oct 05, 7:57AM CDT
Here’s how to trade the exchange-traded funds for small caps, the Dow 30, S&P 500 and the Nasdaq 100, whether or not Friday's rally continues.
SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), DIA: 170.76 (+0.39), IWM: 115.74 (+0.23)

Look for Shares of iShares Russell 2000 Index Fund to Potentially Pullback after Yesterday's 1.47% Rise
Comtex SmarTrend(R) - Fri Oct 02, 3:44PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $107.12 to a high of $110.63. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $109.68 on volume of 57.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IWM: 115.74 (+0.23)

Trader's Notebook: Brazil Names Are Alluring, but Stay Away
at The Street - Fri Oct 02, 8:00AM CDT
Stocks like Petrobras or Vale are serial disappointers.
PBR: 5.67 (-0.01), VALE: 5.48 (+0.21), IWM: 115.74 (+0.23), EWZ: 25.25 (+0.29)

Top ETF Asset Gatherers of September
Sweta Killa - Zacks Investment Research - Thu Oct 01, 8:55AM CDT
September has been a shaky month for both the equity and the fixed-income world, urging investors to jump into the spaces.
VOO: 184.58 (+0.10), SPY: 201.33 (+0.12), IEF: 107.44 (+0.06), SHY: 84.96 (unch), BIL: 45.69 (unch), IWM: 115.74 (+0.23), TLT: 122.28 (+0.32), AAPL: 112.12 (+2.62)

The Trader Daily: Be Glad Third Quarter's Over
at The Street - Thu Oct 01, 6:00AM CDT
Fourth quarter is traditionally bullish, but keep an open mind.
SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), UPL: 7.33 (-0.29), FCG: 7.23 (-0.13), DIA: 170.76 (+0.39), RWR: 90.24 (-0.18), XEC: 122.57 (+0.37), IWM: 115.74 (+0.23), XLU: 43.79 (-0.21), TLT: 122.28 (+0.32)

Trader's Notebook: The Selling in Master Limited Partnerships Was Ludicrous
at The Street - Wed Sep 30, 8:00AM CDT
Highly aggressive, short-term traders should focus on MPLs.
AMJ: 34.68 (+0.12), OKS: 34.80 (+0.09), ETE: 24.88 (+0.23), IWM: 115.74 (+0.23), AAPL: 112.12 (+2.62), WPZ: 34.05 (-0.49)

The Trader Daily: Could This Be Actual Buying?
at The Street - Wed Sep 30, 6:00AM CDT
But let's not read too much into this.
IWM: 115.74 (+0.23)

The Trader Daily: Let's Just Say This Is a Tough Time to Own Stocks
at The Street - Tue Sep 29, 6:00AM CDT
Russell 2000 ETF is the first of the major index ETFs to break beneath the Aug. 24 swing low.
SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), DIA: 170.76 (+0.39), IWM: 115.74 (+0.23)

'Fast Money' Recap: Get Your Bargain-Stock Buying List Ready
at The Street - Tue Sep 29, 4:00AM CDT
The trading panel discussed biotech stocks, Glencore and Apple's iPhone sales weekend.
SBUX: 60.07 (+0.61), HYG: 85.11 (+0.01), HD: 121.33 (+0.27), SPY: 201.33 (+0.12), NKE: 124.94 (+0.03), GILD: 100.65 (-0.16), IBB: 308.45 (+1.25), IWM: 115.74 (+0.23), AAPL: 112.12 (+2.62)

SmarTrend Watching for Potential Rebound in Shares of iShares Russell 2000 Index Fund After 2.80% Loss
Comtex SmarTrend(R) - Mon Sep 28, 3:44PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $107.88 to a high of $111.15. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $110.93 on volume of 55.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IWM: 115.74 (+0.23)

iShares Russell 2000 Index Fund Falls 2.80% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Sep 28, 3:43PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $107.88 to a high of $111.15. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $110.93 on volume of 55.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IWM: 115.74 (+0.23)

How to Trade ETFs Under 'Death Cross' Technical Patterns
at The Street - Mon Sep 28, 8:07AM CDT
It's highly likely that the Nasdaq will confirm a 'death cross' on Monday or Tuesday, which reaffirms that the stock market is in sell strength mode.
SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), NKE: 124.94 (+0.03), DIA: 170.76 (+0.39), IWM: 115.74 (+0.23)

5 Hot ETFs Post Fed Meeting
Sweta Killa - Zacks Investment Research - Thu Sep 24, 9:05AM CDT
These ETFs have been gathering immense investors' love, especially as the Fed stands pat.
JNK: 36.31 (+0.01), EEM: 35.94 (+0.13), QQQ: 106.53 (+0.48), IWM: 115.74 (+0.23), TLT: 122.28 (+0.32), AAPL: 112.12 (+2.62)

10 Twitter Feeds Investors Need to Follow
Ryan McQueeney - Zacks Investment Research - Tue Sep 22, 4:08PM CDT
The social media world can be a valuable tool for investors, and we show you the best profiles to follow on Twitter.
VTI: 103.83 (+0.14), SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), DIA: 170.76 (+0.39), IWM: 115.74 (+0.23), TWTR: 30.85 (+0.53)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading